Emory researchers find Paxil improves memory and brain structure in PTSD sufferers

September 11, 2003

ATLANTA-Emory University researchers have found that paroxetine HCL (Paxil) produces measurable improvement in verbal memory and also increases the size of the hippocampus, a key area of the brain involved in learning and remembering, in persons suffering from post-traumatic stress disorder (PTSD). Their study, which will be published in the Oct. 1 edition of Biological Psychiatry, also found that Paxil significantly reduces the three main symptom clusters of PTSD-re-experiencing the traumatic event; avoidance and emotional numbing related to experiences that recall the traumatic event; and hyperarousal at inappropriate times.

The study was directed by J. Douglas Bremner, MD, associate professor in the Department of Psychiatry and Behavioral Sciences and the Department of Radiology at the Emory University School of Medicine, and Director of Mental Health Research at the Atlanta Veteran's Affairs Medical Center. Eric Vermetten, MD, former research fellow in the Emory Psychiatry Department and now at the University of Utrecht in The Netherlands, was first author of the study. The study, conducted over a 12-month period, was based on 23 persons who suffered with PTSD from a variety of causes, most commonly childhood abuse.

"Many patients with post-traumatic stress disorder suffer impaired memory, often leading them to experience distorted or fragmented memories of the traumatic event. In addition, PTSD patients suffer from problems with new learning and memory as well as concentration," said Dr. Bremner. "The findings of this study indicate that Paxil may help reverse memory loss and increase hippocampal volume, leading to clinically significant improvements in memory and concentration that will improve their work and social function. It may also be true that improved memory will help trauma survivors re-integrate and work through memories of their own traumatic events."

Previous studies have demonstrated that patients with PTSD suffer a decrease in volume of the hippocampus, as well as deficits in hippocampal-based learning and memory as measured with neuropsychological testing. Some studies have associated high levels of cortisol, a hormone that regulates stress, with negative effects on this area of the brain. Studies in animals have also shown that medications such as Paxil have a beneficial effect on the growth and structure of hippocampal neurons.

The study participants were all residents of the state of Connecticut. The patients took 10-50 mg of Paxil (average 20 mg), and were evaluated at the end of 36 weeks. No psychotherapeutic procedure was administered in the study phase, except for supportive therapy. Hippocampal volume was assessed by MRI before and after treatment. Stress parameters and measures of declarative memory function were also evaluated.

Patients in the study experienced significant improvement in verbal declarative memory functions and retention, a four percent increase in the right hippocampus, which affects visual/spatial functioning, and a 5.2 percent increase in their left hippocampus, which controls verbal functioning; decreased cortisol levels, a stress regulator, in the brain; and significant relief of each of the three major symptom clusters of PTSD.

"These study findings reinforce that post-traumatic stress disorder is caused by biologic changes in the brain, and that medications like Paxil play a neurobiologic role in its treatment," added Dr. Bremner. "This data provides clinicians with insight into the complicated nature of treating PTSD, and the importance of effective treatments."

Affecting up to 16 million Americans, PTSD is a debilitating condition that develops after experiencing or witnessing a traumatic event. Of people exposed to traumatic events, as many as 15 percent will develop PTSD. Traumatic events can include car accidents, natural disasters, physical or sexual assault, terrorist attack and robbery. To be diagnosed with PTSD, people must experience intense fear, helplessness or horror and experience each of the three main symptom clusters for more than one month post-exposure to the trauma.

Funding for the study was provided by GlaxoSmithKline, National Institute of Mental Health and the National Center for PTSD. Co-authors include Meena Vythilingam, MD and Dennis S. Charney, MD, Program for Mood and Anxiety Disorders, National Institute of Mental Health; and Steven M. Southwick, M.D., Department of Psychiatry, Yale University School of Medicine.
Media Contacts: Kathi Baker, 404-727-9371, kobaker@emory.edu
Janet Christenbury, 404-727-8599, jmchris@emory.edu

Emory University Health Sciences Center

Related Mental Health Articles from Brightsurf:

Mental health strained by disaster
A new study found that suicide rates increase during all types of disasters -- including severe storms, floods, hurricanes and ice storms -- with the largest overall increase occurring two years after a disaster.

The mental health impact of pandemics for front line health care staff
New research shows the impact that pandemics have on the mental health of front-line health care staff.

World Mental Health Day -- CACTUS releases report of largest researcher mental health survey
On the occasion of 'World Mental Health Day' 2020, CACTUS, a global scientific communications company, has released a global survey on mental health, wellbeing and fulfilment in academia.

Mental illness, mental health care use among police officers
A survey study of Texas police officers examines how common mental illness and mental health care use are in a large urban department.

COVID-19 outbreak and mental health
The use of online platforms to guide effective consumption of information, facilitate social support and continue mental health care delivery during the COVID-19 pandemic is discussed in this Viewpoint.

COVID-19 may have consequences for mental health
The COVID-19 pandemic appears to be adversely affecting mental health among hospitalised patients, the healthcare professionals treating them and the general population.

Mental health outcomes among health care workers during COVID-19 pandemic in Italy
Symptoms of posttraumatic stress disorder, depression, anxiety and insomnia among health care workers in Italy during the COVID-19 pandemic are reported in this observational study.

Mental ill health 'substantial health concern' among police, finds international study
Mental health issues among police officers are a 'substantial health concern,' with around 1 in 4 potentially drinking at hazardous levels and around 1 in 7 meeting the criteria for post traumatic stress disorder and depression, finds a pooled data analysis of the available international evidence, published online in Occupational & Environmental Medicine.

Examining health insurance nondiscrimination policies with mental health among gender minority individuals
A large private health insurance database was used to examine the association between between health insurance nondiscrimination policies and mental health outcomes for gender minority individuals.

Mental health care for adolescents
Researchers examined changes over time in the kinds of mental health problems for which adolescents in the United States received care and where they got that care in this survey study with findings that should be interpreted within the context of several limitations including self-reported information.

Read More: Mental Health News and Mental Health Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.